---

title: "The Mediterranean Diet and Cardiovascular Disease: Evidence From PREDIMED" abstract: "The Mediterranean diet — characterized by high consumption of olive oil, nuts, vegetables, legumes, fish, and moderate wine intake — has been extensively studied as a dietary pattern for cardiovascular disease prevention. The PREDIMED (Prevención con Dieta Mediterránea) trial, one of the largest dietary intervention trials ever conducted, found that a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by approximately 30% compared with a low-fat control diet in high-risk adults. Despite a later partial retraction and re-analysis for methodological reasons, the core finding remained robust, establishing the Mediterranean diet as the most evidence-supported dietary pattern for cardiovascular prevention." topic: health author: nonacademicresearch.org Editorial date: 2026-05-09

The Mediterranean Diet and Cardiovascular Disease: Evidence From PREDIMED

Abstract

The Mediterranean diet — characterized by high consumption of olive oil, nuts, vegetables, legumes, fish, and moderate wine intake — has been extensively studied as a dietary pattern for cardiovascular disease prevention. The PREDIMED (Prevención con Dieta Mediterránea) trial, one of the largest dietary intervention trials ever conducted, found that a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by approximately 30% compared with a low-fat control diet in high-risk adults. Despite a later partial retraction and re-analysis for methodological reasons, the core finding remained robust, establishing the Mediterranean diet as the most evidence-supported dietary pattern for cardiovascular prevention.

Background

The Mediterranean diet was first described as a coherent dietary pattern by Ancel Keys and Margaret Keys in the 1970s based on observations of populations in Crete, Greece, and southern Italy who had lower rates of cardiovascular disease than northern Europeans despite high fat intake. Keys attributed this to the pattern's reliance on olive oil rather than animal fats, and on plant-based foods. Subsequent epidemiological research generated consistent associations between greater adherence to Mediterranean dietary patterns and lower cardiovascular and all-cause mortality.

However, association is not causation. Populations eating traditional Mediterranean diets differ from comparison populations in many ways — climate, physical activity, social eating patterns, food culture — making it difficult to isolate the diet itself. The major contribution of the PREDIMED trial was a randomized design that could provide causal evidence.

The Evidence

PREDIMED Trial

PREDIMED (Estruch et al., 2013, New England Journal of Medicine) randomized 7,447 participants in Spain at high cardiovascular risk (but without established disease) to three arms: a Mediterranean diet supplemented with extra-virgin olive oil (1 liter/week provided), a Mediterranean diet supplemented with mixed nuts (30g/day provided), or a low-fat control diet (with dietary counseling). The primary outcome was major cardiovascular events (myocardial infarction, stroke, or cardiovascular death).

The trial was stopped early after a median follow-up of 4.8 years because the interim analysis showed that both Mediterranean diet arms had substantially lower cardiovascular event rates than the control. The combined Mediterranean diet groups reduced major cardiovascular events by approximately 30% (HR 0.70 for olive oil arm, HR 0.72 for nut arm) relative to the control.

In 2018, the paper was partially retracted and republished (Estruch et al., 2018, New England Journal of Medicine) after an investigation found that some participants in the trial had not been properly randomized — in some cases, whole families at the same address were assigned to the same arm. The investigators re-analyzed the data excluding affected participants and using statistical methods appropriate for cluster assignments. The revised analysis found nearly identical results: HR 0.69 for the olive oil arm and 0.72 for the nut arm. The core finding was robust to the correction.

PREDIMED-Plus

A successor trial, PREDIMED-Plus, is ongoing (as of 2026) and adds a caloric restriction and physical activity component to the Mediterranean diet intervention in people with metabolic syndrome. Interim findings from over 6,000 participants confirm that the intervention produces weight loss and improvements in cardiometabolic markers.

Observational Evidence

Prior to PREDIMED, a large body of prospective cohort data supported the Mediterranean diet. Trichopoulou et al. (2003, New England Journal of Medicine) published findings from the Greek EPIC cohort showing that a one-point increase in a 10-point Mediterranean diet adherence score was associated with a 6% reduction in mortality. Sofi et al. (2010, American Journal of Clinical Nutrition) meta-analyzed 18 prospective studies with over 2 million participants and found that greater adherence to the Mediterranean diet was associated with 9% lower all-cause mortality, 9% lower cardiovascular mortality, and 6% lower cancer incidence.

These associations have been documented in non-Mediterranean populations, including large U.S. cohorts, suggesting that the diet's benefits are not limited to Mediterranean cultural contexts.

Which Components Matter?

Research on dietary components within the Mediterranean diet suggests that no single component accounts for all of the benefit — the pattern matters. However, extra-virgin olive oil and nuts (the components directly supplemented in PREDIMED) and high vegetable and legume intake have the strongest individual evidence. Processed red meat and refined carbohydrates, which the Mediterranean diet minimizes, have independent associations with cardiovascular risk.

Counterarguments

Some critics note that PREDIMED compared the Mediterranean diet to a "low-fat" control diet that was not very different from the Mediterranean diet in some participants, since the control group also received dietary counseling toward a healthier pattern and was already eating a relatively good diet. The comparison may underestimate the Mediterranean diet's absolute benefit relative to a typical Western diet.

Others argue that the benefits observed in PREDIMED may not be fully attributable to the diet itself, since trial participants who received food provisions (olive oil and nuts) may have felt more engaged and motivated to adhere to the full dietary pattern, creating a compliance difference beyond the specific food items.

What We Can Conclude

The PREDIMED trial provides the strongest randomized evidence for any specific dietary pattern's cardiovascular effects. A Mediterranean diet — high in extra-virgin olive oil, nuts, vegetables, legumes, and fish, with minimal processed foods and red meat — reduces major cardiovascular events by approximately 30% in high-risk populations over a 5-year horizon.

The Mediterranean diet is now consistently endorsed by major cardiology and nutrition bodies as the best-evidenced dietary pattern for cardiovascular prevention. It is notable for what it is not: a low-fat diet. The evidence supports a caloric pattern focused on food quality and variety rather than macronutrient restriction.

References

• Estruch, R., et al. (2013, republished 2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378, e34. https://doi.org/10.1056/NEJMoa1800389
• Sofi, F., et al. (2010). Adherence to Mediterranean diet and health status: Meta-analysis. American Journal of Clinical Nutrition, 92(5), 1189–1196. https://doi.org/10.3945/ajcn.2010.29673
• Trichopoulou, A., et al. (2003). Adherence to a Mediterranean diet and survival in a Greek population. New England Journal of Medicine, 348(26), 2599–2608. https://doi.org/10.1056/NEJMoa025039
• de Lorgeril, M., et al. (1999). Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation, 99(6), 779–785. https://doi.org/10.1161/01.CIR.99.6.779
• Martínez-González, M.A., et al. (2022). PREDIMED Plus: Rationale, design, and current interim results. American Journal of Clinical Nutrition, 115(6), 1519–1528. https://doi.org/10.1093/ajcn/nqac021